AU8277582A - Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna- hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccines containing them - Google Patents

Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna- hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccines containing them

Info

Publication number
AU8277582A
AU8277582A AU82775/82A AU8277582A AU8277582A AU 8277582 A AU8277582 A AU 8277582A AU 82775/82 A AU82775/82 A AU 82775/82A AU 8277582 A AU8277582 A AU 8277582A AU 8277582 A AU8277582 A AU 8277582A
Authority
AU
Australia
Prior art keywords
hybride
dna
virus
plasmic
hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU82775/82A
Inventor
Friedrich Deinhardt
Klaus Von Der Helm
Ernst L. Winnacker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3112338A external-priority patent/DE3112338C2/en
Application filed by Individual filed Critical Individual
Publication of AU8277582A publication Critical patent/AU8277582A/en
Abandoned legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU82775/82A 1981-03-28 1982-03-26 Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna- hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccines containing them Abandoned AU8277582A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP3112338.4 1981-03-28
DE3112338A DE3112338C2 (en) 1981-03-28 1981-03-28 Use of hybridization probes for the detection of HAV
PCT/EP1982/000066 WO1982003408A1 (en) 1981-03-28 1982-03-26 Method for the preparation of a dna-hybride,containing the complementary genome of the hepatitis a virus,the dna-hybride itself,the plasmic vector contain it,the specific proteins of the virus coded by the dna-hybride and vaccins containing them

Publications (1)

Publication Number Publication Date
AU8277582A true AU8277582A (en) 1982-10-19

Family

ID=25792219

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82775/82A Abandoned AU8277582A (en) 1981-03-28 1982-03-26 Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna- hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccines containing them

Country Status (1)

Country Link
AU (1) AU8277582A (en)

Similar Documents

Publication Publication Date Title
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
AU7966987A (en) Empty viral capsid vaccines
DE3176404D1 (en) Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
ZA826154B (en) Infectious bronchitis vaccines for poultry, process for the preparation of such vaccines, process for preventing infectious broachitis and infectious bronchitis virus strain
GB2212511B (en) Hepatitis c virus
GB2199328A (en) Translation of mrna
EP0466815A4 (en) Infectious targetted replication-defective virion
NZ211880A (en) Immunogenic, leukemia-associated viral proteins and vaccines
AU506385B2 (en) Hepatitis b virus; isolation for vaccines
PT75643B (en) Method for preparing dna,recombinant dna hosts containing them and polipeptides
AU8746582A (en) Hepatitis b virus e type antigen
DE3266294D1 (en) Method for the preparation of antigens of the viral hepatitis nanb, and application to the preparation of a reaction agent allowing the diagnosis and prognosis of infections caused by the viruses of viral hepatitis
ZA848857B (en) Psoralen inactivated double-stranded rna viral vaccines
JPS57144227A (en) Manufacture of b type hepatitis vaccine
BG50281A3 (en) Method for the preparation of a recombination dna expression vector
AU1076983A (en) Infectious bronchitis vaccines
GB2111829B (en) A process for the preparation of lyophilized vaccine against duck hepatitis
EP0245456A4 (en) Aids virus gene expression.
AU3597089A (en) Method for producing nonhyperglycosylated hepatitis b virus proteins
EP0518313A3 (en) Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
IL76417A (en) Vaccine for hepatitis a virus based on strain hm-175
LTIP1795A (en) Process for preparing protein derived from the envelope gene of human immunodeficiency virus type i and a vaccine containing said protein
EP0549964A3 (en) Process for preparing a virus inactivated prothrombin complex concentrate
AU8277582A (en) Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna- hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccines containing them
AU561920B2 (en) Hepatitis b and hep non a, non b safe biological products